Futurewise Research, a leading market intelligence firm, has released an in-depth market report on the Immune Repertoire ...

Industries are using AI, Digital PLM and Digital Thread, resulting in a transparent adoption that helps satisfy changing ...

March 31, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq ... address multibillion-dollar markets.” Antiviral Product Pipeline Overview We apply our proprietary structure-based drug ...

BioLife Solutions is poised to benefit from the booming cell and gene therapy sector. Read more to see my investment strategy ...

Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses ...

Tivoxavir marboxil’s potential as a single dose therapeutic agent for bird flu supported by significant antiviral activity in three well accepted ...

The Global Confocal Raman Spectroscopy Market is poised for steady and substantial growth, with its market valuation expected to rise from USD 313.99 million in 2023 to USD 584.09 million by 2032, ...

Verified Market Research®, a leading provider of business intelligence and market analysis is thrilled to announce the ...

The following predictions are based on firsthand interactions with clients, investors, consultants, and other industry ... to adapt and drive product development forward. Pharma is looking to ...

Supply chain shortages have dominated headlines for several months, and the pharma industry ... risks for the industry due to shortcuts being taken that are not based on product safety and quality.

Tivoxavir marboxil's potential as a single dose therapeutic agent for bird flu supported by significant antiviral activity in three well accepted animal models and positive Phase 1 data Ongoing FDA ...